Toshi A. Furukawa
Toshi A. Furukawa
Professor of Clinical Epidemiology, Kyoto University
Verified email at
Cited by
Cited by
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
A Cipriani, TA Furukawa, G Salanti, JR Geddes, JPT Higgins, R Churchill, ...
The lancet 373 (9665), 746-758, 2009
The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being
TA Furukawa, RC Kessler, T Slade, G Andrews
Psychological medicine 33 (2), 357-362, 2003
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
A Cipriani, TA Furukawa, G Salanti, A Chaimani, LZ Atkinson, Y Ogawa, ...
Focus 16 (4), 420-429, 2018
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
JR Geddes, SM Carney, C Davies, TA Furukawa, DJ Kupfer, E Frank, ...
The Lancet 361 (9358), 653-661, 2003
Imputing missing standard deviations in meta-analyses can provide accurate results
TA Furukawa, C Barbui, A Cipriani, P Brambilla, N Watanabe
Journal of clinical epidemiology 59 (1), 7-10, 2006
Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative
RC Kessler, JG Green, MJ Gruber, NA Sampson, E Bromet, M Cuitan, ...
International journal of methods in psychiatric research 19 (S1), 4-22, 2010
The performance of the Japanese version of the K6 and K10 in the World Mental Health Survey Japan
TA Furukawa, N Kawakami, M Saitoh, Y Ono, Y Nakane, Y Nakamura, ...
International journal of methods in psychiatric research 17 (3), 152-158, 2008
GRADE guidelines: 12. Preparing summary of findings tables—binary outcomes
GH Guyatt, AD Oxman, N Santesso, M Helfand, G Vist, R Kunz, J Brozek, ...
Journal of clinical epidemiology 66 (2), 158-172, 2013
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis
A Cipriani, X Zhou, C Del Giovane, SE Hetrick, B Qin, C Whittington, ...
The Lancet 388 (10047), 881-890, 2016
GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles—continuous outcomes
GH Guyatt, K Thorlund, AD Oxman, SD Walter, D Patrick, TA Furukawa, ...
Journal of clinical epidemiology 66 (2), 173-183, 2013
Twelve‐month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002–2003
N Kawakami, T Takeshima, Y Ono, H Uda, Y Hata, Y Nakane, H Nakane, ...
Psychiatry and clinical neurosciences 59 (4), 441-452, 2005
Cross-cultural validation of the Beck Depression Inventory-II in Japan
M Kojima, TA Furukawa, H Takahashi, M Kawai, T Nagaya, S Tokudome
Psychiatry research 110 (3), 291-299, 2002
Systematic review and meta-analysis of cannabis treatment for chronic pain
E Martín-Sánchez, TA Furukawa, J Taylor, JLR Martin
Pain medicine 10 (8), 1353-1368, 2009
Antidepressants plus benzodiazepines for major depression
TA Furukawa, D Streiner, LT Young, Y Kinoshita
Cochrane Database of Systematic Reviews, 2001
Supported employment for adults with severe mental illness
Y Kinoshita, TA Furukawa, K Kinoshita, M Honyashiki, IM Omori, ...
Cochrane Database of Systematic Reviews, 2013
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review
TA Furukawa, N Watanabe, R Churchill
The British Journal of Psychiatry 188 (4), 305-312, 2006
'Third wave'cognitive and behavioural therapies versus other psychological therapies for depression
V Hunot, THM Moore, DM Caldwell, TA Furukawa, P Davies, H Jones, ...
Cochrane Database of Systematic Reviews, 2013
Psychotherapy for depression among incurable cancer patients
T Akechi, T Okuyama, J Onishi, T Morita, TA Furukawa
Cochrane Database of Systematic Reviews, 2008
Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses
TA Furukawa, GH Guyatt, LE Griffith
International journal of epidemiology 31 (1), 72-76, 2002
Waiting list may be a nocebo condition in psychotherapy trials: A contribution from network meta‐analysis
TA Furukawa, H Noma, DM Caldwell, M Honyashiki, K Shinohara, H Imai, ...
Acta Psychiatrica Scandinavica 130 (3), 181-192, 2014
The system can't perform the operation now. Try again later.
Articles 1–20